53 results on '"Temsirolimus -- Research"'
Search Results
2. Study Data from Virginia Commonwealth University Update Understanding of Bioscience (The Cytoprotective and Cytotoxic Functions of Autophagy in Response to mTOR Inhibitors)
3. Investigators from Mayo Clinic Have Reported New Data on Liver Cancer (Therapeutic Efficacy of Temsirolimus In a Patient-derived Model of Metastatic Fibrolamellar Hepatocellular Carcinoma)
4. Researchers from Kangwon National University Detail New Studies and Findings in the Area of Cancer (Development of Tat-fused Drug Binding Protein To Improve Anti-cancer Effect of Mammalian Target of Rapamycin Inhibitors)
5. First Affiliated Hospital of Guangxi Medical University Researchers Provide New Data on Lung Cancer [Exploring the prognosis value, immune correlation, and drug responsiveness prediction of homeobox C6 (HOXC6) in lung adenocarcinoma]
6. Research on Insulin Resistance Described by a Researcher at Carol Davila University of Medicine and Pharmacy (mTOR Dysregulation, Insulin Resistance, and Hypertension)
7. Study Results from Bioinformatics Group Update Understanding of Chikungunya Virus (Drug repurposing approach against chikungunya virus: an in vitro and in silico study)
8. Reports from Creighton University Highlight Recent Findings in Ovarian Cancer (A Phase Ii Evaluation of Temsirolimus With Carboplatin and Paclitaxel Followed By Temsirolimus Consolidation In Clear Cell Ovarian Cancer: an Nrg Oncology Trial)
9. New Obesity, Fitness and Wellness Study Findings Recently Were Reported by Researchers at National University of Singapore (Why Is Rapamycin Not a Rapalog?)
10. Researchers at Kyungpook National University Have Published New Study Findings on Cancer (Temsirolimus Enhances Anti-Cancer Immunity by Inducing Autophagy-Mediated Degradation of the Secretion of Small Extracellular Vesicle PD-L1)
11. Studies from University of Texas Southwestern Medical Center Provide New Data on Neurofibromatosis Type 2 (Neurofibromatosis Type Ii and Facial Paralysis: Clinical Evaluation and Management)
12. Study Findings on Lung Diseases and Conditions Detailed by a Researcher at Army Medical University (Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021)
13. Researchers at Northwestern University Feinberg School of Medicine Release New Study Findings on Thyroid Cancer (Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly ...)
14. Studies from Jiangsu University in the Area of Lung Cancer Described (Construction of a Prognostic Model for Lung Adenocarcinoma Based On M6a/m5c/m1a Genes)
15. Findings from University Hospital Provide New Insights into Molecular Graphics and Modelling (In Silico Development of New Pet Radiopharmaceuticals From Mtor Inhibitors)
16. Findings from Ohio State University Broaden Understanding of Mantle Cell Lymphoma (Resistance to PRMT5 Targeted Therapy in Mantle Cell Lymphoma)
17. Study Findings on Neuroendocrine Cancer Detailed by a Researcher at OhioHealth (A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors)
18. Study Data from University of California San Francisco (UCSF) Provide New Insights into Hepatitis B Virus (Phase Ii Trial of the Combination of Temsirolimus and Sorafenib In Advanced Hepatocellular Carcinoma With Tumor Mutation Profiling)
19. New Solid Cancer Findings from Dartmouth-Hitchcock Medical Center Described (Phase I Study of Docetaxel and Temsirolimus In Refractory Solid Tumors)
20. New Data from University of Texas MD Anderson Cancer Center Illuminate Research in Solid Cancer (A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors)
21. Findings from University of Michigan Has Provided New Data on Salivary Gland Cancer (Mtor Inhibition Ablates Cisplatin-resistant Salivary Gland Cancer Stem Cells)
22. Researchers from Memorial Sloan-Kettering Cancer Center Describe Findings in Carcinomas (Waxing and Waning Pattern of Mtor Inhibitor-associated Pneumonitis In Renal Cell Carcinoma Patients: a Retrospective Observational Study)
23. Study Findings on Breast Cancer Are Outlined in Reports from Carol Davila University of Medicine and Pharmacy (PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects)
24. New Drug Metabolism and Pharmacokinetics Findings from First Affiliated Hospital of Zhengzhou University Described (Rapalogues as hCES2A Inhibitors: In Vitro and In Silico Investigations)
25. New Kidney Cancer Findings Has Been Reported by Researchers at Affiliated Hospital of Hubei University of Arts and Science (Preclinical evidence that MNK/eIF4E inhibition by cercosporamide enhances the response to antiangiogenic TKI and mTOR ...)
26. Findings from Gifu Pharmaceutical University Broaden Understanding of Lung Diseases and Conditions (Analysis of drug-induced interstitial lung disease using the Japanese Adverse Drug Event Report database)
27. New Findings from Otto-von-Guericke-University in Meningeal Neoplasms Provides New Insights [Klf4(K409q)-mutated Meningiomas Show Enhanced Hypoxia Signaling and Respond To Mtorc1 Inhibitor Treatment]
28. Research Results from University Hospital Munster Update Knowledge of Multiple Myeloma (Combination Treatment Targeting mTOR and MAPK Pathways Has Synergistic Activity in Multiple Myeloma)
29. New Life Science Study Findings Have Been Reported from Tampere University (Therapeutic Targeting of Lck Tyrosine Kinase and Mtor Signaling In T-cell Acute Lymphoblastic Leukemia)
30. Researchers' from University of Michigan Report Details of New Studies and Findings in the Area of Neuroblastomas (KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory ...)
31. Studies from Northeast Normal University Yield New Data on Antineoplastics (Tumor regression and potentiation of polymeric vascular disrupting therapy through reprogramming of a hypoxia microenvironment with temsirolimus)
32. New Adrenocortical Carcinoma Findings Has Been Reported by Researchers at University of Naples Federico II (The role of mTOR pathway as target for treatment in adrenocortical cancer)
33. Goethe-University Reports Findings in Prostate Cancer (Influence of the Hdac Inhibitor Valproic Acid On the Growth and Proliferation of Temsirolimus-resistant Prostate Cancer Cells In Vitro)
34. Researchers from University of Iowa Report on Findings in Endometrial Cancer (Tp53 Sequencing and P53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added To Frontline Chemotherapy In Endometrial Cancer: an Nrg Oncology/gynecologic ...)
35. New Findings on Personalized Medicine Described by Investigators at Bogazici University (Understanding the Link Between Inflammasome and Apoptosisthrough the Response of Thp-1 Cells Against Drugs Using Droplet-based Microfluidics Br)
36. Study Findings on Neurooncology Are Outlined in Reports from University of New South Wales (DIPG-21. DIPG cells alter the permeability of the blood-brain barrier in the brainstem leading to treatment failure)
37. Research on Precision Oncology Discussed by Researchers at University of Texas MD Anderson Cancer Center (Multi-site desmoplastic small round cell tumors are genetically related and immune-cold)
38. New Data from West China Hospital of Sichuan University Illuminate Research in Bladder Cancer (Fatty Acid Synthase Is the Key Regulator of Fatty Acid Metabolism and Is Related to Immunotherapy in Bladder Cancer)
39. New Neuroendocrine Cancer Study Results from Mayo Clinic Described (Phase Ii Trial of Bevacizumab Monotherapy In Pancreatic Neuroendocrine Tumors)
40. Researchers from Harvard Medical School Report Details of New Studies and Findings in the Area of Antineoplastics (A Phase I Study of Azd2171 and Temsirolimus In Patients With Advanced Gynecological Malignancies)
41. Analysis of PTEN and HIF-1(alpha) and correlation with efficacy in patients with advanced renal cell carcinoma treated with temsirolimus versus interferon-(alpha)
42. Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group
43. New Helicobacter pylori Findings from Huazhong University of Science and Technology Described [Helicobacter Urease Suppresses Cytotoxic Cd8(+) T-cell Responses Through Activating Myh9-dependent Induction of Pd-l1]
44. Studies from Department of Urology Have Provided New Information about Andrology and Urology (Assessment of Prognosis By Established Prognosis Scores and Physicians' Judgement In Mrcc Patients: an Analysis of the Star-tor Registry)
45. Researchers from Youjiang Medical University for Nationalities Detail Findings in Carcinomas (Immune-related Long Non-coding Rnas Can Serve As Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma)
46. Research Reports on Antineoplastics from Lombardi Comprehensive Cancer Center Provide New Insights (A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies)
47. Reports from University of the Ryukyus Highlight Recent Research in Squamous Cell Carcinoma (Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma)
48. Researchers from College of Science Discuss Findings in COVID-19 [Inhibition of Sars-cov-2 Main Protease 3cl(Pro) By Means of Alpha-ketoamide and Pyridone-containing Pharmaceuticals Using In Silico Molecular Docking]
49. Findings from Guizhou University Provide New Insights into Personalized Medicine (Immunogenomic Profiling and Classification of Prostate Cancer Based on HIF-1 Signaling Pathway)
50. Findings from University of Chicago Medicine in Head and Neck Cancer Reported (A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO ...)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.